Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study

Résultats de recherche

• Actif

  Clinical Pharmacology Research Group

  Douxfils, J., Dogne, J., Musuamba Tshinanu, F., Masereel, B., Wieërs, G., Haguet, H., RONVAUX, L., Donis, N., Morimont, L., Evrard, J., Siriez, R., Gillot, C., FAVRESSE, J., BOUVY, C., Djokoto, H., Didembourg, M., David, C., Melchionda, S., Maloteau, V., Boucher, A., Devel, P., Modaffari, E., Vandeputte, M., De Messemaeker, A., Decarpentrie, J., Vassart, J. & De Groote, A.

  1/04/22 → …

  Projet: Axe de recherche

  • Neutralizing Antibody 100%
  • Patient 87%
  • COVID-19 80%
  • Direct Oral Anticoagulant 79%
  • Severe Acute Respiratory Syndrome Coronavirus 2 78%

• The BIOCOAG project : Biological assessment of the control of anticoagulation

  Douxfils, J., Mullier, F., Dogne, J., Siriez, R. & Evrard, J.

  1/09/11 → …

  Projet: Recherche

  • Direct Oral Anticoagulant 100%
  • Thrombin 45%
  • Blood Clotting Factor 10a Inhibitor 43%
  • Assay 39%
  • Rivaroxaban 34%